Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of doxycycline in early to moderate ATTR amyloidosis
2007-005287-27Phase 2Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxycycline in transthyretin amyloidosis (ATTR), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Response. Started Oct 2007; status: terminated.
02
Drugs
doxycycline
03
Conditions
transthyretin amyloidosis (ATTR)
Beyond the preview
Go deeper on 2007-005287-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005287-27.